IRAM - Instituto de Radio Medicina

Santiago 7630370

0 studies enrolling now · 2 studies all time

What they study most

First Line Non-Small Cell Lung Cancer, PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC

Studies at this site

• Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06) — Running, not enrolling
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed